ERRATA: Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus (Clinics (2011) 66(4) (529–533), (S1807593222014545), (10.1590/S1807-59322011000400002));Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus

Clinics

Volumn 66, Issue 4, 2011, Pages 529-533

  Costa, Marcia Helena Soares ^a,b   Domenice, Sorahia ^b   Toledo, Rodrigo Almeida ^c   Delmar Muniz, L ^c   Latronico, Ana Claudia ^a,b   Pinto, Emilia Modolo ^d   Toledo, Sergio Pereira Almeida ^c   Mendonca, Berenice Bilharinho ^b   Fragoso, Maria Candida Barisson Villares ^a,b  

^a Unidade de Suprarrenal   (Brazil)

^b Laboratorio de Hormonios e Genetica Molecular LIM/42   (Brazil)

^c Unidade de Endocrinologia Genetica LIM/25   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adrenocortical hyperplasia; Expression; GIPR; MEN1

Indexed keywords

EID: 79958709827     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011001200029     Document Type: Erratum

References (37)

1. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671, doi: 10.1210/jc.86.12.5658.
2. Thakker RV. Multiple endocrine neoplasia. Horm Res. 2001;56 Suppl 1:67-72.
3. Falchetti A, Marini F, Tonelli F, Brandi ML. Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes. Ann Endocrinol (Paris). 2005;66:195-205.
4. Schaefer S, Shipotko M, Meyer S, et al. Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Eur J Endocrinol. 2008;158:699-704, doi: 10.1530/EJE-07-0635.
5. Beckers A, Abs R, Willems PJ, et al. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab. 1992;75:564-570, doi: 10.1210/jc.75.2.564.
6. Langer P, Cupisti K, Bartsch DK, et al. Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg. 2002;26:891-896, doi: 10.1007/s00268-002-6492-4.
7. Skogseid B, Larsson C, Lindgren PG, et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1992;75:76-81, doi: 10.1210/jc.75.1.76.
8. Waldmann J, Bartsch DK, Kann PH, Fendrich V, Rothmund M, Langer P. Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg. 2007;392:437-443, doi: 10.1007/s00423-006-0124-7.
9. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U SA. 1971;68:820-823, doi: 10.1073/pnas.68.4. 820.
10. Agarwal SK, Lee Burns A, Sukhodolets KE, et al. Molecular pathology of the MEN1 gene. Ann N Y Acad Sci. 2004;1014:189-198, doi: 10.1196/annals.1294.020.
11. Chandrasekharappa SC, Teh BT. Functional studies of the MEN1 gene. J Intern Med. 2003;253:606-615, doi: 10.1046/j.1365-2796.2003.01165.x.
12. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol. 2000;20:6147-6158, doi: 10.1128/MCB.20.16.6147-6158.2000.
13. Karnik SK, Hughes CM, Gu X, et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA. 2005;102:14659-14664, doi: 10.1073/pnas.0503484102.
14. Milne TA, Hughes CM, Lloyd R, et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA. 2005;102:749-754, doi: 10.1073/pnas.0408836102.
15. Burgess JR, Harle RA, Tucker P, et al. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg. 1996;131:699-702.
16. Gortz B, Roth J, Speel EJ, et al. MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer. 1999;80:373-379, doi: 10.1002/(SICI)1097-0215(19990129)80:3,373::AID-IJC7.3.0.CO;2-B.
17. Skogseid B, Rastad J, Gobl A, et al. Adrenal lesion in multiple endocrine neoplasia type 1. Surgery. 1995;118:1077-1082, doi: 10.1016/S0039-6060(05)80117-5.
18. Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med. 1998;243:465-470, doi: 10.1046/j.1365-796.1998.00275.x.
19. Toledo RA, Mendonca BB, Fragoso MC, et al. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis. Clinics (Sao Paulo). 2010;65:407-415.
20. Mazzuco TL, Chabre O, Sturm N, Feige JJ, Thomas M. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology. 2006;147:782-790, doi: 10.1210/en.2005-0921.
21. Bertherat J, Contesse V, Louiset E, et al. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab. 2005;90:1302-1310, doi: 10.1210/jc.2004-1256.
22. Costa MH, Domenice S, Latronico AC, et al. Analysis of glucosedependent insulinotropic peptide receptor (GIPR) and luteinizing hormone receptor (LHCGR) expression in human adrenocortical hyperplasia. Arq Bras Endocrinol Metabol. 2009;53:326-331.
23. Costa MH, Lacroix A. Cushing's syndrome secondary to ACTHindependent macronodular adrenal hyperplasia. Arq Bras Endocrinol Metabol. 2007;51:1226-1237.
24. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab. 2004;15:375-382.
25. Toledo RA, Lourenco DM, Coutinho FL, et al. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2007;67:377-384, doi: 10.1111/j.1365-2265.2007.02895.x.
26. Chen LC, Neubauer A, Kurisu W, et al. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci USA. 1991;88:3847-3851, doi: 10.1073/pnas.88.9.3847.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408, doi: 10.1006/meth.2001.1262.
28. Kubota A, Yamada Y, Yasuda K, et al. Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and-insensitive pathways. Biochem Biophys Res Commun. 1997;235:171-5, doi: 10.1006/bbrc.1997.6743.
29. Trumper A, Trumper K, Trusheim H, Arnold R, Goke B, Horsch D. Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol. 2001;15:1559-1570, doi: 10.1210/me.15.9.1559.
30. N'Diaye N, Tremblay J, Hamet P, De Herder WW, Lacroix A. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. J Clin Endocrinol Metab. 1998;83:2781-2785, doi: 10.1210/jc.83.8.2781.
31. Tsagarakis S, Tsigos C, Vassiliou V, et al. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies. J Clin Endocrinol Metab. 2001;86:583-589, doi: 10.1210/jc.86.2.583.
32. Horvath A, Boikos S, Giatzakis C, et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet. 2006;38:794-800, doi: 10.1038/ng1809.
33. Horvath A, Mericq V, Stratakis CA. Mutation in PDE8B, a cyclic AMPspecific phosphodiesterase in adrenal hyperplasia. N Engl J Med. 2008;358:750-752, doi: 10.1056/NEJMc0706182.
34. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 2000;26:89-92, doi: 10.1038/79238.
35. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature. 1989;340:692-696, doi: 10.1038/340692a0.
36. Antonini SR, Baldacchino V, Tremblay J, Hamet P, Lacroix A. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome. Clin Endocrinol (Oxf). 2006;64:29-36, doi: 10.1111/j.1365-2265.2005.02411.x.
37. Chabre O, Liakos P, Vivier J, et al. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab. 1998;83:3134-143, doi: 10.1210/jc.83.9.3134